FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Hum Gene Ther / Sustained Interleukin-10 Transgene Expression Following Intr...
Human gene therapy2019; 31(1-2); 110-118; doi: 10.1089/hum.2019.195

Sustained Interleukin-10 Transgene Expression Following Intra-Articular AAV5-IL-10 Administration to Horses.

Abstract: Joint trauma leads to post-traumatic inflammation with upregulation of inflammatory cytokines and degradative enzymes. If severe enough, this response can lead to irreversible post-traumatic osteoarthritis. Interleukin-10 (IL-10), a cytokine with potent anti-inflammatory effects, has been shown to have chondroprotective effects. A gene therapy approach using a vector to overexpress IL-10 in the joint represents a feasible method of delivering sustained high doses of IL-10 to post-traumatic joints. We hypothesized that an AAV5 vector overexpressing IL-10 would result in rapid and sustained IL-10 expression following direct intra-articular injection and that this increase would not be reflected in systemic circulation. In addition, we hypothesized that intra-articular AAV5-IL-10 injection would not induce a local inflammatory response. Twelve horses were assigned to either treatment (AAV5-IL-10-injected) or control (PBS-injected) groups. Middle carpal joints were injected with 10 vector genomes/joint or phosphate-buffered saline (PBS) alone (3 mL). Serial synovial fluid samples were analyzed for inflammatory changes, IL-10 concentration, and vector genome copy number. Serum samples were also analyzed for IL-10 concentration and vector genome copy number. Synovial membrane was collected on day 84. Synovial fluid IL-10 was significantly increased within 48 h of AAV5-IL-10 injection and remained increased, compared to PBS-injected joints, until day 84. Serum IL-10 was not different between groups. Vector administration did not cause a significant synovial inflammatory response. Vector genomes were detectable in the plasma, synovial fluid, and synovial membrane of AAV5-IL-10-injected horses only. IL-10 has the potential to modulate the articular inflammatory response, thereby protecting cartilage from degradation and osteoarthritis. This study demonstrates the feasibility and efficiency of intra-articular AAV5-IL-10, and future studies investigating the chondroprotective effects of IL-10 in inflamed joints are warranted.
Get Full Text
Publication Date: 2019-12-18 PubMed ID: 31773987PubMed Central: PMC7872004DOI: 10.1089/hum.2019.195Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study tries to ascertain the potential of gene therapy in managing joint inflammation through intra-articular administration of an anti-inflammatory cytokine, Interleukin-10 (IL-10). It demonstrates that this method provides sustained release of IL-10, controlling inflammation without triggering systemic effects or local inflammation in horse subjects.

Research Context

  • Post-traumatic inflammation caused by joint trauma can lead to severe consequences such as irreversible post-traumatic osteoarthritis if the responses of inflammatory cytokines and degradative enzymes are intense.
  • The cytokine, Interleukin-10 (IL-10) is noted for its potent anti-inflammatory effects and ‘chondroprotective’ properties – that is, it is capable of shield the cartilage.
  • The researchers propose using gene therapy, specifically an AAV5 vector aiding the overexpression of IL-10, as a strategic method to deliver high, prolonged doses of IL-10 to affected joints.

Methods and Hypotheses

  • The scientists hypothesized that using the AAV5 vector would stimulate immediate and persistent IL-10 expression following intra-articular injection, which would not affect systemic circulation or instigate a local inflammatory response.
  • To affirm these theories, researchers divided twelve horses into a treatment group and a control group, injecting 10 vector genomes/joint or phosphate-buffered saline (PBS) into the middle carpal joints of horses respectively.
  • Samples of synovial fluid were taken periodically and analysed to monitor IL-10 concentration, inflammatory changes, and vector genome copy number. Serum samples were similarly analysed for IL-10 concentration and vector genome.

Findings and Conclusions

  • The findings confirm that IL-10 in synovial fluid dramatically increased within 48 hours of AAV5-IL-10 injection and maintained this high level until day 84 when compared with PBS-injected joints.
  • There were no significant differences in the serum IL-10 levels between both groups, nor any notable synovial inflammatory response caused by vector administration.
  • The vector genomes could only be identified in the plasma, synovial fluid, and synovial membrane of horses injected with the AAV5-IL-10.
  • These findings underscore the potential of IL-10 as a modulator of the articular inflammatory response, thus protecting cartilage from degradation and osteoarthritis.
  • This research successfully highlights the feasibility and effectiveness of the intra-articular AAV5-IL-10 method, and encourages further research into the chondroprotective effects of IL-10 in inflamed joints.

Cite This Article

APA
Moss KL, Jiang Z, Dodson ME, Linardi RL, Haughan J, Gale AL, Grzybowski C, Engiles JE, Stefanovski D, Robinson MA, Ortved KF. (2019). Sustained Interleukin-10 Transgene Expression Following Intra-Articular AAV5-IL-10 Administration to Horses. Hum Gene Ther, 31(1-2), 110-118. https://doi.org/10.1089/hum.2019.195

Publication

Human gene therapy
ISSN: 1557-7422
NlmUniqueID: 9008950
Country: United States
Language: English
Volume: 31
Issue: 1-2
Pages: 110-118

Researcher Affiliations

Moss, Kaitlyn L
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Jiang, Zibin
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Dodson, Michael E
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Linardi, Renata L
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Haughan, Joanne
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Gale, Alexis L
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Grzybowski, Cara
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Engiles, Julie E
  • Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania.
Stefanovski, Darko
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
Robinson, Mary A
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.
  • Pennsylvania Equine Toxicology & Research Center, West Chester University, West Chester, Pennsylvania.
Ortved, Kyla F
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania.

MeSH Terms

  • Animals
  • Biomarkers
  • Cytokines / metabolism
  • Dependovirus
  • Disease Models, Animal
  • Gene Expression
  • Genetic Therapy / methods
  • Genetic Vectors / administration & dosage
  • Genetic Vectors / genetics
  • Genome, Viral
  • Horses
  • Humans
  • Immunohistochemistry
  • Inflammation Mediators / metabolism
  • Injections, Intra-Articular
  • Interleukin-10 / genetics
  • Osteoarthritis / genetics
  • Osteoarthritis / pathology
  • Osteoarthritis / therapy
  • Parvovirinae / genetics
  • Synovial Fluid / metabolism
  • Synovial Membrane / metabolism
  • Synovial Membrane / pathology
  • Transgenes

Grant Funding

  • T35 OD010919 / NIH HHS

Conflict of Interest Statement

No competing financial interests exist for any of the authors.

References

This article includes 33 references
  1. Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based Survey.. Arthritis Care Res (Hoboken) 2016 May;68(5):574-80.
    pmc: PMC4769961pubmed: 26315529doi: 10.1002/acr.22721google scholar: lookup
  2. nTorio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204 2013. .
  3. Buckwalter JA, Brown TD. Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis.. Clin Orthop Relat Res 2004 Jun;(423):7-16.
    pubmed: 15232420
  4. nArthritis and the Military: Support Arthritis Research at the Department of Defense. https://www.arthritis.org/Documents/Sections/Advocate/DoD-Leave-Behind-Green.pdf (last accessed March8, 2018)
  5. Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzì RM, Marcu KB. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis.. Eur Cell Mater 2011 Feb 24;21:202-20.
    pmc: PMC3937960pubmed: 21351054doi: 10.22203/ecm.v021a16google scholar: lookup
  6. Olson SA, Horne P, Furman B, Huebner J, Al-Rashid M, Kraus VB, Guilak F. The role of cytokines in posttraumatic arthritis.. J Am Acad Orthop Surg 2014 Jan;22(1):29-37.
    pubmed: 24382877doi: 10.5435/jaaos-22-01-29google scholar: lookup
  7. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.. Arthritis Rheum 2005 Jan;52(1):128-35.
    pubmed: 15641080doi: 10.1002/art.20776google scholar: lookup
  8. Moroguchi A, Ishimura K, Okano K, Wakabayashi H, Maeba T, Maeta H. Interleukin-10 suppresses proliferation and remodeling of extracellular matrix of cultured human skin fibroblasts.. Eur Surg Res 2004 Jan-Feb;36(1):39-44.
    pubmed: 14730222doi: 10.1159/000075073google scholar: lookup
  9. Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.. J Clin Invest 1994 Dec;94(6):2489-92.
    pmc: PMC330082pubmed: 7989607doi: 10.1172/jci117618google scholar: lookup
  10. Ortved KF, Begum L, Stefanovski D, Nixon AJ. AAV-mediated Overexpression of IL-10 Mitigates the Inflammatory Cascade in Stimulated Equine Chondrocyte Pellets.. Curr Gene Ther 2018;18(3):171-179.
    pubmed: 29749312doi: 10.2174/1566523218666180510165123google scholar: lookup
  11. Schulze-Tanzil G, Zreiqat H, Sabat R, Kohl B, Halder A, Müller RD, John T. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders.. Curr Gene Ther 2009 Aug;9(4):306-15.
    pubmed: 19534651doi: 10.2174/156652309788921044google scholar: lookup
  12. Finnegan A, Kaplan CD, Cao Y, Eibel H, Glant TT, Zhang J. Collagen-induced arthritis is exacerbated in IL-10-deficient mice.. Arthritis Res Ther 2003;5(1):R18-24.
    pmc: PMC154422pubmed: 12716449doi: 10.1186/ar601google scholar: lookup
  13. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Britti D, De Maio M, Caputi AP. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.. Eur Cytokine Netw 2001 Oct-Dec;12(4):568-80.
    pubmed: 11781183
  14. Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy.. Nat Rev Rheumatol 2014 Jan;10(1):11-22.
    pmc: PMC4402210pubmed: 24189839doi: 10.1038/nrrheum.2013.159google scholar: lookup
  15. Daya S, Berns KI. Gene therapy using adeno-associated virus vectors.. Clin Microbiol Rev 2008 Oct;21(4):583-93.
    pmc: PMC2570152pubmed: 18854481doi: 10.1128/cmr.00008-08google scholar: lookup
  16. Watson RS, Broome TA, Levings PP, Rice BL, Kay JD, Smith AD, Gouze E, Gouze JN, Dacanay EA, Hauswirth WW, Nickerson DM, Dark MJ, Colahan PT, Ghivizzani SC. scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints.. Gene Ther 2013 Jun;20(6):670-7.
    pmc: PMC3577988pubmed: 23151520doi: 10.1038/gt.2012.81google scholar: lookup
  17. Ortved K, Wagner B, Calcedo R, Wilson J, Schaefer D, Nixon A. Humoral and cell-mediated immune response, and growth factor synthesis after direct intraarticular injection of rAAV2-IGF-I and rAAV5-IGF-I in the equine middle carpal joint.. Hum Gene Ther 2015 Mar;26(3):161-71.
    pmc: PMC4367237pubmed: 25705927doi: 10.1089/hum.2014.050google scholar: lookup
  18. Watson Levings RS, Smith AD, Broome TA, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.. Hum Gene Ther Clin Dev 2018 Jun;29(2):101-112.
    pmc: PMC6007806pubmed: 29869535doi: 10.1089/humc.2017.143google scholar: lookup
  19. Drittanti L, Rivet C, Manceau P, Danos O, Vega M. High throughput production, screening and analysis of adeno-associated viral vectors.. Gene Ther 2000 Jun;7(11):924-9.
    pubmed: 10849551doi: 10.1038/sj.gt.3301191google scholar: lookup
  20. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S93-105.
    pubmed: 20864027doi: 10.1016/j.joca.2010.05.031google scholar: lookup
  21. Bevaart L, Aalbers CJ, Vierboom MP, Broekstra N, Kondova I, Breedveld E, Hauck B, Wright JF, Tak PP, Vervoordeldonk MJ. Safety, Biodistribution, and Efficacy of an AAV-5 Vector Encoding Human Interferon-Beta (ART-I02) Delivered via Intra-Articular Injection in Rhesus Monkeys with Collagen-Induced Arthritis.. Hum Gene Ther Clin Dev 2015 Jun;26(2):103-12.
    pubmed: 26086763doi: 10.1089/humc.2015.009google scholar: lookup
  22. Kay JD, Gouze E, Oligino TJ, Gouze JN, Watson RS, Levings PP, Bush ML, Dacanay A, Nickerson DM, Robbins PD, Evans CH, Ghivizzani SC. Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus.. J Gene Med 2009 Jul;11(7):605-14.
    pmc: PMC2876984pubmed: 19384892doi: 10.1002/jgm.1334google scholar: lookup
  23. Goodrich LR, Phillips JN, McIlwraith CW, Foti SB, Grieger JC, Gray SJ, Samulski RJ. Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis.. Mol Ther Nucleic Acids 2013 Feb 5;2(2):e70.
    pmc: PMC3586798pubmed: 23385523doi: 10.1038/mtna.2012.61google scholar: lookup
  24. Goodrich LR, Grieger JC, Phillips JN, Khan N, Gray SJ, McIlwraith CW, Samulski RJ. scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.. Gene Ther 2015 Jul;22(7):536-45.
    pmc: PMC5567794pubmed: 25902762doi: 10.1038/gt.2015.21google scholar: lookup
  25. Watson Levings RS, Broome TA, Smith AD, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC. Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model.. Hum Gene Ther Clin Dev 2018 Jun;29(2):90-100.
    pmc: PMC6007808pubmed: 29869540doi: 10.1089/humc.2017.142google scholar: lookup
  26. Pillay S, Zou W, Cheng F, Puschnik AS, Meyer NL, Ganaie SS, Deng X, Wosen JE, Davulcu O, Yan Z, Engelhardt JF, Brown KE, Chapman MS, Qiu J, Carette JE. Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.. J Virol 2017 Sep 15;91(18).
    pmc: PMC5571256pubmed: 28679762doi: 10.1128/jvi.00391-17google scholar: lookup
  27. Hemphill DD, McIlwraith CW, Samulski RJ, Goodrich LR. Adeno-associated viral vectors show serotype specific transduction of equine joint tissue explants and cultured monolayers.. Sci Rep 2014 Jul 29;4:5861.
    pmc: PMC4894424pubmed: 25069854doi: 10.1038/srep05861google scholar: lookup
  28. Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, Lee BHL, Guse K. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.. Arthritis Rheumatol 2018 Nov;70(11):1757-1768.
    pubmed: 30044894doi: 10.1002/art.40668google scholar: lookup
  29. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor.. Annu Rev Immunol 2001;19:683-765.
    pubmed: 11244051doi: 10.1146/annurev.immunol.19.1.683google scholar: lookup
  30. Riley JK, Takeda K, Akira S, Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action.. J Biol Chem 1999 Jun 4;274(23):16513-21.
    pubmed: 10347215doi: 10.1074/jbc.274.23.16513google scholar: lookup
  31. Blauvelt A, Chiricozzi A. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.. Clin Rev Allergy Immunol 2018 Dec;55(3):379-390.
    pmc: PMC6244934pubmed: 30109481doi: 10.1007/s12016-018-8702-3google scholar: lookup
  32. Martino AT, Suzuki M, Markusic DM, Zolotukhin I, Ryals RC, Moghimi B, Ertl HC, Muruve DA, Lee B, Herzog RW. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.. Blood 2011 Jun 16;117(24):6459-68.
    pmc: PMC3123017pubmed: 21474674doi: 10.1182/blood-2010-10-314518google scholar: lookup
  33. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
    pmc: PMC3626203pubmed: 23610661doi: 10.1302/2046-3758.111.2000132google scholar: lookup

Citations

This article has been cited 8 times.
  1. Li X, Shen L, Deng Z, Huang Z. New treatment for osteoarthritis: Gene therapy.. Precis Clin Med 2023 Jun;6(2):pbad014.
    doi: 10.1093/pcmedi/pbad014pubmed: 37333626google scholar: lookup
  2. Thampi P, Samulski RJ, Grieger JC, Phillips JN, McIlwraith CW, Goodrich LR. Gene therapy approaches for equine osteoarthritis.. Front Vet Sci 2022;9:962898.
    doi: 10.3389/fvets.2022.962898pubmed: 36246316google scholar: lookup
  3. Crabtree E, Uribe K, Smith SM, Roberts D, Salmon JH, Bower JJ, Song L, Bastola P, Hirsch ML, Gilger BC. Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.. PLoS One 2022;17(8):e0270972.
    doi: 10.1371/journal.pone.0270972pubmed: 35980983google scholar: lookup
  4. Yoon DS, Lee KM, Cho S, Ko EA, Kim J, Jung S, Shim JH, Gao G, Park KH, Lee JW. Cellular and Tissue Selectivity of AAV Serotypes for Gene Delivery to Chondrocytes and Cartilage.. Int J Med Sci 2021;18(15):3353-3360.
    doi: 10.7150/ijms.56760pubmed: 34522160google scholar: lookup
  5. Hahn AK, Batushansky A, Rawle RA, Prado Lopes EB, June RK, Griffin TM. Effects of long-term exercise and a high-fat diet on synovial fluid metabolomics and joint structural phenotypes in mice: an integrated network analysis.. Osteoarthritis Cartilage 2021 Nov;29(11):1549-1563.
    doi: 10.1016/j.joca.2021.08.008pubmed: 34461226google scholar: lookup
  6. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Hamilton NA, Kusano K, Nagata SI. Whole-genome resequencing using genomic DNA extracted from horsehair roots for gene-doping control in horse sports.. J Equine Sci 2020;31(4):75-83.
    doi: 10.1294/jes.31.75pubmed: 33376443google scholar: lookup
  7. Cassimeris L, Engiles JB, Galantino-Homer H. Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis.. PLoS One 2020;15(12):e0232920.
    doi: 10.1371/journal.pone.0232920pubmed: 33301461google scholar: lookup
  8. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Kusano K, Nagata SI. Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control.. Genes (Basel) 2020 Apr 23;11(4).
    doi: 10.3390/genes11040457pubmed: 32340130google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.